Resultados de la craneoplastia con el uso de cemento Genta 1 en los defectos óseos postraumáticos / Cranioplasty Results Using Genta 1 Cement in Posttraumatic Bone Defects

Introducción: la reconstrucción de defectos de la bóveda craneana constituye un reto para el cirujano. Durante las últimas décadas, muchas han sido las variantes quirúrgicas para su aplicación, así como los materiales utilizados para ello. Objetivo: mostrar los resultados en la realización de craneoplastias con el uso de cemento Genta 1 en pacientes con defecto óseo del cráneo, secundario a traumatismo craneoencefálico. Métodos: se realizó un estudio de serie de casos que abarca desde el año 2009 hasta septiembre de 2014 a 20 pacientes con traumatismo craneoencefálico que les dejó como secuela un defecto óseo del cráneo, requiriendo posteriormente de craneoplastia. Resultados: predominó en el adulto joven y el sexo masculino. En cuanto al diámetro del defecto, predominó el pequeño, seguido de los medianos. En relación con la topografía, prevalecieron los frontales derechos. Predominó la modalidad de abordaje tardío de la craneoplastia luego de la aparición del defecto. Las principales complicaciones fueron el hematoma subgaleal y la deformidad cosmética residual. Conclusiones: la mayoría de los defectos tratados fueron pequeños y medianos, localizados en la región frontal derecha, la modalidad de abordaje más empleada fue la tardía y existió un mínimo de complicaciones(AU)

Introduction: The reconstruction of defects of the cranial cavity constitutes a surgical challenge. Many have been the surgical variants for its application during the last decades, as well as the material used for it. Objectives: To evaluate the results in craneoplasty realized with cement Genta 1 in patients with osseous defect secondary to cranial injury. Methods: It was done a descriptive, retrospective and longitudinal study extended from 2009 to 2014 in 20 patients with cranial injury that left them as consequence an skull's osseous defect which needed subsequent craneoplasty. Results: The injuries predominated in young adults and male sex. Small defects were the more frequent, followed by middle sized and only a large one. In relation with topography, they prevailed in right frontal region of the skull. The belated approach was the most used treatment adopted for the craneoplasty. Subgaleal haematoma and the residual cosmetic deformity were the main complications. Conclusions: Majority of cranial defects were small and middle sized, topographycally situated on the right frontal region and the belated approach was the most frequent treatment adopted for the craneoplasty(AU)

Is bone transplantation the gold standard for repair of alveolar bone defects?

New strategies to fulfill craniofacial bone defects have gained attention in recent years due to the morbidity of autologous bone graft harvesting. We aimed to evaluate the in vivo efficacy of bone tissue engineering strategy using mesenchymal stem cells associated with two matrices (bovine bone mineral and α-tricalcium phosphate), compared to an autologous bone transfer. A total of 28 adult, male, non-immunosuppressed Wistar rats underwent a critical-sized osseous defect of 5 mm diameter in the alveolar region. Animals were divided into five groups. Group 1 (n = 7) defects were repaired with autogenous bone grafts; Group 2 (n = 5) defects were repaired with bovine bone mineral free of cells; Group 3 (n = 5) defects were repaired with bovine bone mineral loaded with mesenchymal stem cells; Group 4 (n = 5) defects were repaired with α-tricalcium phosphate free of cells; and Group 5 (n = 6) defects were repaired with α-tricalcium phosphate loaded with mesenchymal stem cells. Groups 2-5 were compared to Group 1, the reference group. Healing response was evaluated by histomorphometry and computerized tomography. Histomorphometrically, Group 1 showed 60.27% ± 16.13% of bone in the defect. Groups 2 and 3 showed 23.02% ± 8.6% (p = 0.01) and 38.35% ± 19.59% (p = 0.06) of bone in the defect, respectively. Groups 4 and 5 showed 51.48% ± 11.7% (p = 0.30) and 61.80% ± 2.14% (p = 0.88) of bone in the defect, respectively. Animals whose bone defects were repaired with α-tricalcium phosphate and mesenchymal stem cells presented the highest bone volume filling the defects; both were not statistically different from autogenous bone.